Produktbild: Advances in Statistical Methods for the Health Sciences
- 13%

Advances in Statistical Methods for the Health Sciences Applications to Cancer and AIDS Studies, Genome Sequence Analysis, and Survival Analysis

13% sparen

166,99 € UVP 192,59 €

inkl. gesetzl. MwSt., Versandkostenfrei

Lieferung nach Hause

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

22.11.2006

Herausgeber

Jean-Louis Auget + weitere

Verlag

Birkhäuser Boston

Seitenzahl

540

Maße (L/B/H)

26/18,5/3,5 cm

Gewicht

1124 g

Auflage

2007 edition

Sprache

Englisch

ISBN

978-0-8176-4368-3

Beschreibung

Rezension

From the reviews:



"This edited volume is an outgrowth of an ‘International Conference on Statistical Methods’ so-called in the Health Sciences in 2004. It is a well presented volume with lists of tables and figures. … Clearly this volume covers a wide range of topics pertaining to statistical methods in the area of health sciences. … In summary, it is a welcome addition to the literature of statistical science." (Technometrics, Vol. 49 (3), August, 2007)

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

22.11.2006

Herausgeber

Verlag

Birkhäuser Boston

Seitenzahl

540

Maße (L/B/H)

26/18,5/3,5 cm

Gewicht

1124 g

Auflage

2007 edition

Sprache

Englisch

ISBN

978-0-8176-4368-3

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern

  • Produktbild: Advances in Statistical Methods for the Health Sciences
  • Preface Contributors List of Tables List of Figures Part I: Prognostic Studies and General Epidemiology Systematic Review of Multiple Studies of Prognosis: The Feasibility of Obtaining Individual Patient Data \ D.G. Altman, M. Trivella, F. Pezzella, and A.L. Harris On Statistical Approaches for the Multivariate Analysis of Prognostic Marker Studies \ N. Holländer and W. Sauerbrei Where Next for Evidence Synthesis of Prognostic Marker Studies? Improving the Quality and Reporting of Primary Studies to Facilitate Clinically Relevant Evidence-Based Results \ R.D. Riley, K.R. Abrams, P.C. Lambert, A.J. Sutton, and D.G. Altman Part II: Pharmacovigilance Sentinel Event Methods for Monitoring Unanticipated Adverse Events \ P.A. Lachenbruch and J. Wittes Spontaneous Reporting System Modelling for the Evaluation of Automatic Signal Generation Methods in Pharmacovigilance \ E. Roux, F. Thiessard, A. Fourier, B. Bégaud, and P. Tubert-Bitter Part III: Quality of Life Latent Covariates in Generalized Linear Models: A Rasch Model Approach \ K.B. Christensen Sequential Analysis of Quality of Life Measurements with the Mixed Partial Credit Model \ V. Sébille, T. Challa, and M. Mesbah A Parametric Degradation Model Used in Reliability, Survival Analysis, and Quality of Life \ M. Nikulin, L. Gerville-Réache, and S. Orazio Agreement Between Two Ratings with Different Ordinal Scales \ S. Natarajan, M.B. McHenry, S. Lipsitz, N. Klar, and S. Lipshultz Part IV: Survival Analysis The Role of Correlated Frailty Models in Studies of Human Health, Ageing, and Longevity \ A. Wienke, P. Lichtenstein, K. Czene, and A.I. Yashin Prognostic Factors and Prediction of Residual Survival for Hospitalized Elderly Patients \ M.L. Calle, P. Roura, A. Arnau, A. Yáñez, and A.Leiva New Models and Methods for Survival Analysis of Experimental Data \ G.V. Semenchenko, A.I. Yashin, T.E. Johnson, and J.W. Cypser Uniform Consistency for Conditional Lifetime Distribution Estimators Under Random Right-Censorhip \ P. Deheuvels and G. Derzko Sequential Estimation for the Semiparametric Additive Hazard Model \ L. Bordes and C. Breuils Variance Estimation of a Survival Function with Doubly Censored Failure Time Data \ C. Zhu and J. Sun Part V: Clustering Statistical Models and Artificial Neural Networks: Supervised Classification and Prediction Via Soft Trees \ A. Ciampi and Y. Lechevallier Multilevel Clustering for Large Databases \ Y. Lechevallier and A. Ciampi Neural Networks: An Application for Predicting Smear Negative Pulmonary Tuberculosis \ A.M. Santos, B.B. Pereira, J.M. Seixas, F.C.Q. Mello, and A.L. Kritski Assessing Drug Resistance in HIV Infection Using Viral Load Using Segmented Regression \ H. Liang, W.-Y. Tan, and X. Xiong Assessment of Treatment Effects on HIV Pathogenesis Under Treatment by State Space Models \ W.-Y. Tan, P. Zhang, X. Xiong, and P. Flynn Part VI: Safety and Efficacy Assessment Safety Assessment Versus Efficacy Assessment \ M.A. Foulkes Cancer Clinical Trials with Efficacy and Toxicity Endpoints: A Simulation Study to Compare Two Nonparametric Methods \ A. Letierce and P. Tubert-Bitter Safety Assessment in Pilot Studies When Zero Events are Observed \ R.E. Carter and R.F. Woolson Part VII: Clinical Designs An Assessment of Up-and-Down Designs and Associated Estimators in Phase I Trials \ H.K.T. Ng, S.G. Mohanty, and N. Balakrishnan Design of Multicentre Clinical Trials with Random Enrolment \ V.V. Anisimov and V.V. Fedorov Statistical Methods for Combining Clinical Trial Phases II and III \ N. Stallard and S. Tod